Vivo Capital IX, LLC

Insider Reports History

Entity
Company
Location
192 Lytton Avenue, Palo Alto, CA
Signature
/s/ Hongbo Lu, as a managing member of Vivo Opportunity, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vivo Capital IX, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. 10%+ Owner Common Stock 2.47M $49.4M $20.00 May 5, 2022 Indirect
IO Biotech, Inc. 10%+ Owner Common Stock 3.16M $3.27M $1.04 Aug 9, 2023 By Vivo Opportunity Fund Holdings, L.P.
IO Biotech, Inc. 10%+ Owner Common Stock 3.02M $3.12M $1.04 Aug 9, 2023 By: Vivo Capital Fund IX, L.P.
IO Biotech, Inc. 10%+ Owner Common Stock 3.02M $3.12M $1.04 Nov 9, 2021 Direct
IO Biotech, Inc. 10%+ Owner Warrants (Right to Buy) 3.16M Aug 9, 2023 By Vivo Opportunity Fund Holdings, L.P.
IO Biotech, Inc. 10%+ Owner Series C Preferred Stock 0 Nov 9, 2021 Direct

Insider Reports Filed by Vivo Capital IX, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IOBT IO Biotech, Inc. Aug 9, 2023 2 $6.39M 4 Aug 10, 2023 10%+ Owner
TARS Tarsus Pharmaceuticals, Inc. May 5, 2022 1 -$65.8K 4 May 5, 2022 10%+ Owner
TARS Tarsus Pharmaceuticals, Inc. May 2, 2022 3 -$6.87M 4 May 4, 2022 10%+ Owner
IOBT IO Biotech, Inc. Nov 9, 2021 3 $9.1M 4 Nov 12, 2021 10%+ Owner
IOBT IO Biotech, Inc. Nov 4, 2021 0 $0 3 Nov 4, 2021 10%+ Owner
TARS Tarsus Pharmaceuticals, Inc. Jun 23, 2021 3 -$1.66M 4 Jun 25, 2021 10%+ Owner
TARS Tarsus Pharmaceuticals, Inc. Jun 21, 2021 2 -$5.86M 4 Jun 25, 2021 10%+ Owner